IndraLab

Statements

QTCI inhibits KCNH2. 1 / 1

| 1

reach

"Most QTCI prolonging drugs can inhibit the function of recombinant hERG K+ channels, consequently in vitro hERG assays are used widely as front-line screens in cardiac safety testing of novel chemical entities."

16967047

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

QTCI inhibits KCNH2. 1 / 1

INDRA sources:

Databases

Reading